Computaional Design and Evaluation of Antibacterial agents - Latif, Abdalkader;Al-Bayati, Redha;Al-Jumaily, Essam
46,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
23 °P sammeln
  • Broschiertes Buch

Infectious disease remains as major health problem due to the rapid development of resistance to existing antibacterial drugs. The spread of resistance among Gram negative bacterial like Pseudomonas aeruginosa, increase the limitation in the in the availability of therapeutic. The purpose of this book is to present an update perspective upon the use of Quinoline-2-one derivative as antibacterial agents, as well as computational design and prediction the binding with target protein to enhancing their antibacterial efficacy, in order to highlight potential new solutions to cope with infections…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Infectious disease remains as major health problem due to the rapid development of resistance to existing antibacterial drugs. The spread of resistance among Gram negative bacterial like Pseudomonas aeruginosa, increase the limitation in the in the availability of therapeutic. The purpose of this book is to present an update perspective upon the use of Quinoline-2-one derivative as antibacterial agents, as well as computational design and prediction the binding with target protein to enhancing their antibacterial efficacy, in order to highlight potential new solutions to cope with infections resulting from drug-resistance bacteria. The Quinoline-2-one derivatives that designed and synthesized in this study presented novel and promising antibacterial agents, which bind with target protein (DNA gyrase) and maintained the cleavage complex with DNA and being lethal to bacteria. Design and evaluation of antibacterial activity of Quinoline-2-one derivatives opening new directions in drug discovery process.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Abdalkader Latif has an extensive experience in Protein modeling, Structural Based Drug Design and bioevaluation of New classes of designed synthesized chemical compounds with pharmacological activity. Being the author of numerous research projects, papers and patent in this field.